HEADER METAL BINDING PROTEIN 25-OCT-22 8BFG TITLE SOLUTION STRUCTURE OF HUMAN APO/CALMODULIN G113R (G114R) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALMODULIN-1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: THE SAMPLE CONTAINED NATIVE CALMODULIN, THAT WAS COMPND 7 SEGMENTALLY ISOTOPE LABELLED WITH 13C AND 15N FROM AMINO ACIDS 81- COMPND 8 148, WHILE AMINO ACIDS 1-80 WERE UNLABELLED. THUS, EVEN THOUGH THE COMPND 9 WHOLE NATIVE CALMODULIN SEQUENCE WAS PRESENT IN THE SAMPLE, ONLY THE COMPND 10 STRUCTURE OF AMINO ACIDS 81-148 WAS DETERMINED. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CALM1, CALM, CAM, CAM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CALCIUM-BINDING PROTEIN CALCIUM SIGNALLING CARDIAC ARRHYTHMIA, METAL KEYWDS 2 BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.WIMMER,C.V.HOLLER,N.M.PETERSSON,M.B.BROHUS,M.NIEMELAE, AUTHOR 2 M.T.OVERGAARD,H.IWAI REVDAT 2 17-JAN-24 8BFG 1 JRNL REVDAT 1 04-OCT-23 8BFG 0 JRNL AUTH C.V.HOLLER,N.M.PETERSSON,M.BROHUS,M.A.NIEMELA,E.D.IVERSEN, JRNL AUTH 2 M.T.OVERGAARD,H.IWAI,R.WIMMER JRNL TITL ALLOSTERIC CHANGES IN PROTEIN STABILITY AND DYNAMICS AS JRNL TITL 2 PATHOGENIC MECHANISM FOR CALMODULIN VARIANTS NOT AFFECTING JRNL TITL 3 CA 2+ COORDINATING RESIDUES. JRNL REF CELL CALCIUM V. 117 02831 2023 JRNL REFN ISSN 1532-1991 JRNL PMID 37995470 JRNL DOI 10.1016/J.CECA.2023.102831 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : YASARA 21.12.19 REMARK 3 AUTHORS : YASARA BIOSCIENCES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TWO STEPS: 1) IN VACUO WITH THE NOVA REMARK 3 FORCE FIELD, 2) IN EXPLICIT WATER WITH THE YASARA FORCE FIELD REMARK 4 REMARK 4 8BFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1292126140. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.1 REMARK 210 PH : 6.64 REMARK 210 IONIC STRENGTH : 128 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.2 MM AA 81-148: U-13C,15N REMARK 210 CALMODULIN G113R, 5 MM EDTA, 100 REMARK 210 MM POTASSIUM CHLORIDE, 2 MM NAN3, REMARK 210 20 MM HEPES, 0.1 MM TSP-D4, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D HNCO; 3D HN(CA)CO; REMARK 210 3D HNCA; 3D HNCACB; 3D CBCA(CO) REMARK 210 NH; COCA; 3D H(CCO)NH; 3D (H) REMARK 210 CC(CO)NH; (HB)CB(CGCD)HD; (HB) REMARK 210 CB(CGCDCE)HE; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY ALIPHATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.97, CARA 1.8.4, TOPSPIN REMARK 210 3.6.6 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 GLN A 3 REMARK 465 LEU A 4 REMARK 465 THR A 5 REMARK 465 GLU A 6 REMARK 465 GLU A 7 REMARK 465 GLN A 8 REMARK 465 ILE A 9 REMARK 465 ALA A 10 REMARK 465 GLU A 11 REMARK 465 PHE A 12 REMARK 465 LYS A 13 REMARK 465 GLU A 14 REMARK 465 ALA A 15 REMARK 465 PHE A 16 REMARK 465 SER A 17 REMARK 465 LEU A 18 REMARK 465 PHE A 19 REMARK 465 ASP A 20 REMARK 465 LYS A 21 REMARK 465 ASP A 22 REMARK 465 GLY A 23 REMARK 465 ASP A 24 REMARK 465 GLY A 25 REMARK 465 THR A 26 REMARK 465 ILE A 27 REMARK 465 THR A 28 REMARK 465 THR A 29 REMARK 465 LYS A 30 REMARK 465 GLU A 31 REMARK 465 LEU A 32 REMARK 465 GLY A 33 REMARK 465 THR A 34 REMARK 465 VAL A 35 REMARK 465 MET A 36 REMARK 465 ARG A 37 REMARK 465 SER A 38 REMARK 465 LEU A 39 REMARK 465 GLY A 40 REMARK 465 GLN A 41 REMARK 465 ASN A 42 REMARK 465 PRO A 43 REMARK 465 THR A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 GLU A 47 REMARK 465 LEU A 48 REMARK 465 GLN A 49 REMARK 465 ASP A 50 REMARK 465 MET A 51 REMARK 465 ILE A 52 REMARK 465 ASN A 53 REMARK 465 GLU A 54 REMARK 465 VAL A 55 REMARK 465 ASP A 56 REMARK 465 ALA A 57 REMARK 465 ASP A 58 REMARK 465 GLY A 59 REMARK 465 ASN A 60 REMARK 465 GLY A 61 REMARK 465 THR A 62 REMARK 465 ILE A 63 REMARK 465 ASP A 64 REMARK 465 PHE A 65 REMARK 465 PRO A 66 REMARK 465 GLU A 67 REMARK 465 PHE A 68 REMARK 465 LEU A 69 REMARK 465 THR A 70 REMARK 465 MET A 71 REMARK 465 MET A 72 REMARK 465 ALA A 73 REMARK 465 ARG A 74 REMARK 465 LYS A 75 REMARK 465 MET A 76 REMARK 465 LYS A 77 REMARK 465 ASP A 78 REMARK 465 THR A 79 REMARK 465 ASP A 80 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 114 22.32 -66.19 REMARK 500 2 ARG A 113 87.42 52.44 REMARK 500 2 GLU A 114 30.67 -72.68 REMARK 500 3 ARG A 113 76.43 55.37 REMARK 500 3 GLU A 114 23.97 -68.10 REMARK 500 4 GLU A 114 32.30 -71.94 REMARK 500 5 GLU A 114 24.90 -67.81 REMARK 500 6 GLU A 114 33.22 -73.50 REMARK 500 7 GLU A 114 35.01 -73.26 REMARK 500 8 GLU A 114 28.54 -70.28 REMARK 500 9 GLU A 114 27.16 -69.90 REMARK 500 10 ARG A 113 73.23 57.56 REMARK 500 10 GLU A 114 26.19 -69.57 REMARK 500 11 ARG A 113 75.38 53.23 REMARK 500 11 GLU A 114 25.70 -70.07 REMARK 500 12 GLU A 114 25.82 -68.40 REMARK 500 13 GLU A 114 23.60 -66.94 REMARK 500 14 GLU A 114 27.50 -70.08 REMARK 500 15 GLU A 114 28.46 -71.96 REMARK 500 16 ARG A 113 88.45 48.37 REMARK 500 16 GLU A 114 23.46 -68.10 REMARK 500 17 ARG A 113 83.04 52.90 REMARK 500 17 GLU A 114 28.57 -72.43 REMARK 500 18 GLU A 114 27.22 -68.45 REMARK 500 19 GLU A 114 32.86 -68.88 REMARK 500 20 ARG A 113 72.08 46.81 REMARK 500 20 GLU A 114 24.98 -68.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8BD2 RELATED DB: PDB REMARK 900 8BD2 CONTAINS THE SAME CALMODULIN VARIANT IN ITS CA-BOUND FORM REMARK 900 RELATED ID: 34765 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF HUMAN APO/CALMODULIN G113R (G114R) DBREF 8BFG A 1 148 UNP P0DP23 CALM1_HUMAN 2 149 SEQADV 8BFG ARG A 113 UNP P0DP23 GLY 114 ENGINEERED MUTATION SEQRES 1 A 148 ALA ASP GLN LEU THR GLU GLU GLN ILE ALA GLU PHE LYS SEQRES 2 A 148 GLU ALA PHE SER LEU PHE ASP LYS ASP GLY ASP GLY THR SEQRES 3 A 148 ILE THR THR LYS GLU LEU GLY THR VAL MET ARG SER LEU SEQRES 4 A 148 GLY GLN ASN PRO THR GLU ALA GLU LEU GLN ASP MET ILE SEQRES 5 A 148 ASN GLU VAL ASP ALA ASP GLY ASN GLY THR ILE ASP PHE SEQRES 6 A 148 PRO GLU PHE LEU THR MET MET ALA ARG LYS MET LYS ASP SEQRES 7 A 148 THR ASP SER GLU GLU GLU ILE ARG GLU ALA PHE ARG VAL SEQRES 8 A 148 PHE ASP LYS ASP GLY ASN GLY TYR ILE SER ALA ALA GLU SEQRES 9 A 148 LEU ARG HIS VAL MET THR ASN LEU ARG GLU LYS LEU THR SEQRES 10 A 148 ASP GLU GLU VAL ASP GLU MET ILE ARG GLU ALA ASP ILE SEQRES 11 A 148 ASP GLY ASP GLY GLN VAL ASN TYR GLU GLU PHE VAL GLN SEQRES 12 A 148 MET MET THR ALA LYS HELIX 1 AA1 SER A 81 ASP A 93 1 13 HELIX 2 AA2 SER A 101 LEU A 112 1 12 HELIX 3 AA3 THR A 117 ARG A 126 1 10 HELIX 4 AA4 TYR A 138 THR A 146 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1